Syndicated Report

Alzheimer’s Disease Treatments and Expectations

April 30, 2019

Research Objectives:

  • Understand the current treatment landscape for Alzheimer’s Disease patients
  • Explore what physicians know about and expect for products in development for Alzheimer’s Disease

Method: 9-minute MicroSurvey via InCrowd
Crowds: US Neurologists
Sample Size: n=100
Fielding Period: March 10-13, 2019
Screening Criteria:
Qualified respondents are US-based neurologists who:

  • Treat at least 10 Alzheimer’s Disease patients in a typical month
  • Are at least somewhat knowledgeable about products in development for the treatment of Alzheimer’s Disease

One key finding:

  • Responding neurologists tend to treat over 30 Alzheimer’s patients a month across all severity levels (39% mild, 38% moderate, 23% severe).

Download the full report now!

  • This field is for validation purposes and should be left unchanged.